Clinical Scorecard: Patient Clinics in Pathology's Evolution
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: Patient Clinics in Pathology's Evolution
Key Mechanisms
Mechanisms or clinical associations described in the source article.
Target Population
Patients or participants described in the source article.
Care Setting
Pathology explanation clinics embedded in care models at Mayo Clinic in Rochester and Florida, Duke Health, Tufts Medical, Endeavor Health, and Michigan Medicine.
Key Highlights
The article describes pathology explanation clinics as connecting patients directly with the pathologist who examined their tissue.
The author argues that plain-language explanations can help patients understand findings and take an active role in treatment decisions.
The article says direct explanation can free ordering physicians' appointment time for treatment planning rather than report interpretation.
The author reports that such clinics have been established at Mayo Clinic in Rochester and Florida, Duke Health, Tufts Medical, Endeavor Health, Michigan Medicine, and other institutions.
The author describes benefits for patient engagement, institutional satisfaction and loyalty, and pathologists' sense of purpose.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients whose care depends on pathology findings, including patients who may find pathology reports difficult to interpret.
The article discusses communication and care-model benefits, not medication prescribing or treatment regimens.
Clinical Best Practices
The author describes explaining pathology findings directly to patients in plain language.
The author describes using the slide, stains, and findings to show how tissue evidence relates to the diagnosis.
The author argues that direct explanations can help patients ask questions and take an active role in treatment decisions.
The author says direct explanations can leave ordering physicians more appointment time for treatment planning.
New research identifies metabolic signatures that could help predict which patients with Chagas disease are most likely to develop serious cardiac complications
